Impact on Patient Care

More documents

Recommendations

Info

A.R.M. Program: Staphylococcus aureus(2000-2008)1009080706050403020100ClindamycinErythromycinNationalNENJPA24
% macrolide resistanceRelationship of Efflux vs.Methylation-Induced Resistance in S. Aureus2000 - 200810080604056% erm58% erm65% erm53% erm36.8 2029.7 35.6effluxmethylation2026.6 25.3 2938.30National NE NJ PA25
Page 1 and 2: Update on Antibacterial Resistance<
Page 3 and 4: Bad Bugs—No Drugs!2 M people will
Page 5 and 6: Major Factors Contributing to theEm
Page 7 and 8: Historical Perspective Until 1989 v
Page 9 and 10: 400 + Hospitals21% Teaching79% Comm
Page 11 and 12: Escherichia coli Leading nosocomial
Page 13 and 14: A.R.M. Program: Escherichia coli(20
Page 15 and 16: Klebsiella pneumoniae Resistance ca
Page 17 and 18: Pseudomonas aeruginosa Inducible, c
Page 19 and 20: Gram-Positive OrganismsIf We Only K
Page 21 and 22: A.R.M. Program: Staph aureus(2000-2
Page 23: Vancomycin ResistantStaphylococcus
Page 27 and 28: A.R.M. Program: Enterococcus faeciu
Page 29 and 30: A.R.M. Program: Streptococcus pneum
Page 31 and 32: Preventing ResistanceUnrealistic pa
Page 33 and 34: Strategies for Overcoming Resistanc
Page 35: Changing the Paradigm: What does th
Page 45 and 46: Program InformationA.R.M. ProgramPa

Impact on Patient Care

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?